The oncoprinter plot indicated that the expression of PIK3CA, PIK3CB, AKT1, and mTOR genes in HCC patients harboured point mutations, copy number changes, and abnormal gene expression in key genes of the PI3K/AKT/mTOR pathway (Fig. 1A). This evidence concerns the gene PIK3CB and hepatocellular carcinoma.